antiphospholipid antibodies
News
10.12.2019
Asclepion Laser Technologies: Steady growth enables investment in the future
On September 9, an extension to the main building of Asclepion Laser Technologies GmbH was inaugurated and the usable floor space almost doubled by a further 2,500 m2 during a […]
21.09.2016
Cynosure Receives Approval to Market SculpSure® in South Korea
“MFDS approval of SculpSure is another major step in our international growth strategy for this breakthrough non-invasive fat-reduction treatment,” said Cynosure President and Chief Executive Officer Michael Davin. “As one […]
24.04.2017
The Product Family of Asclepion Laser Technologies: „Made in Germany“
Asclepion Laser Technologies offers different technologies for a multitude of aesthetic and medical treatments. With new products and follow up models of almost legendary systems like the MCL29 Dermablate, RubyStar, […]